We are live on
!
Find out more
SSCM
Summit Street Capital Management Portfolio holdings
AUM
$707M
1-Year Est. Return
76.8%
This Fund
S&P 500
This Quarter
Est. Return
-2.45%
1 Year Est. Return
+76.8%
3 Year Est. Return
+144.33%
5 Year Est. Return
+200.14%
10 Year Est. Return
+704.53%
AUM
$101M
AUM Growth
-$513K
(-0.51%)
Cap. Flow
+$2.36M
Cap. Flow
% of AUM
2.34%
Top 10 Holdings %
Top 10 Hldgs %
54.31%
Holding
37
New
7
Increased
7
Reduced
2
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molina Healthcare
MOH
|
+$2.89M |
| 2 |
Cirrus Logic
CRUS
|
+$2.76M |
| 3 |
NTRI
NutriSystem, Inc.
NTRI
|
+$2.56M |
| 4 |
CNR
Core Natural Resources Inc
CNR
|
+$2.24M |
| 5 |
Vishay Intertechnology
VSH
|
+$2.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$4.12M |
| 2 |
Myriad Genetics
MYGN
|
+$3.86M |
| 3 |
Capri Holdings
CPRI
|
+$2.5M |
| 4 |
Smith & Wesson
SWBI
|
+$2.24M |
| 5 |
GAP
The Gap Inc
GAP
|
+$1.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.88% |
| 2 | Technology | 20.1% |
| 3 | Financials | 17.19% |
| 4 | Industrials | 13.12% |
| 5 | Consumer Discretionary | 10.48% |
Similar funds
NG
IFM
GHCMRT
AC
JPMIA
LSIA
DIA
SSP
Summit Street Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Summit Street Capital Management held 37 positions worth $101M, down 0.51% from $101M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Summit Street Capital Management's Q1 2018 filing shows 7 new, 7 increased, 2 reduced and 5 closed positions. Its largest new stake was Cirrus Logic: 59,340 shares worth $2.41M. The largest sale was Elevance Health, an estimated $4.12M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 26% a quarter earlier, followed by Technology and Financials.
- Summit Street Capital Management's largest Q1 2018 buy was Cirrus Logic: 59,340 shares worth $2.41M.
- Summit Street Capital Management added most to Molina Healthcare in Q1 2018, an estimated $2.89M increase.
- Summit Street Capital Management's biggest Q1 2018 reduction was Myriad Genetics, cutting an estimated $3.86M.
- Summit Street Capital Management fully exited Elevance Health in Q1 2018, selling an estimated $4.12M.
- Summit Street Capital Management's ten largest holdings make up 54% of its $101M portfolio in Q1 2018.
- Summit Street Capital Management opened 7 new positions and closed 5 in Q1 2018.
- Summit Street Capital Management's portfolio value fell 0.51% quarter-over-quarter to $101M.
Based on Summit Street Capital Management's 13F filing for Q1 2018, filed 15 May 2018.